Learn more

BIOALLIANCE CV

Overview
  • Total Patents
    100
  • GoodIP Patent Rank
    33,268
  • Filing trend
    ⇩ 70.0%
About

BIOALLIANCE CV has a total of 100 patent applications. It decreased the IP activity by 70.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, Taiwan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS, IGENICA INC and KINDRED BIOSCIENCES INC.

Patent filings per year

Chart showing BIOALLIANCE CVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lin Shih-Yao 72
#2 Lin Rong-Hwa 53
#3 Lin Leewen 43
#4 Tsai Yu-Ying 40
#5 Lee Shu-Hua 32
#6 Huang Chiu-Chen 31
#7 Hsieh Yu-Chi 29
#8 Chiang Feng-Lin 12
#9 Lin Shih Yao 11
#10 Lin Rong Hwa 7

Latest patents

Publication Filing date Title
US2017198052A1 Tetravalent anti-PSGL-1 antibodies and uses thereof
KR20170027774A Anti-cd22 antibody-drug conjugates and methods of using thereof
AU2013203422A1 Anti-transferrin receptor antibodies and methods using same
AU2012238260A1 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
TW201125583A Anti-EpCAM antibodies that induce apoptosis of cancer cells and methods using same
ZA201003047B Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
TW201023893A Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
TW200938629A Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
SG172684A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same